Adial Pharmaceuticals, Inc.

ADIL
$2.94 (+ $0.04 + 1.38%)
Last updated: 2026-07-07 19:38 UTC
ADIL Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS00688A1060
CUSIP00688A106
Market Price2.94
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.6
Market Cap$6.6M
Book Value0.19
Price to Book1.305
Beta1.11
52w High1.3
52w Low0.22
Next Earnings DateN/A

Adial Pharmaceuticals, Inc. trades under ticker ADIL on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US00688A1060, CUSIP 00688A106. Also searched as Adial Pharmaceuticals.

Related researchADIL stock priceADIL share priceAdial Pharmaceuticals stockAdial Pharmaceuticals share price00688A106
About the Company
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.
Price History